Tracking CGEM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CG
Cullinan Therapeutics, Inc. (CGEM) short interest & options flow
NASDAQCullinan Therapeutics heads into its November 6 earnings event with a stark gap between a stubbornly bearish lending market and a Street that has spent the past several weeks nudging targets higher. The positioning picture tells a story of persistent, if easing, short pressure. Short interest runs at 16.2% of the free float, roughly 9.6 million shares, down from a month-ago peak…
$11.31+4.72% 1d-24.75% 1w-30.40% 1mClose: 6 Nov 2026
- Market cap
- $728M
- Next earnings
- 13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 7 Nov 2026
CGEM news and analysis
RSSNo long-form analysis yet for CGEM. Pulse alerts and the live data picture are available on ORTEX.
Open CGEM on ORTEX →Want the live picture for CGEM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CGEM — free to start on ORTEX.
Sign up for free →Open CGEM on ORTEX